Start a conversation
Home/Communities/LidoSpra
Li

Prescription products · Product label record

LidoSpra drug information

LIDOSPRA
Oncora Pharma, LLC · TOPICAL

Product NDC: 85477-325

Join the community
CommunityExperiencesReviewsDrug database
Source label information, not individualized medical advice. This record applies to the product and labeler shown below. Compare the exact formulation, strength and country with your package and the current source label.
Generic nameLIDOSPRA
Labeler / manufacturerOncora Pharma, LLC
RouteTOPICAL
Drug classAmide Local Anesthetic / Antiarrhythmic
Product NDC85477-325
Label effective date2026-08-25

Official product label reference

LidoSpra — Oncora Pharma, LLC

This page contains 7 source sections for LIDOSPRA, topical route. Label set 0f1a2c0d-d5d3-4b8f-94f6-0a01b4626959, version 2.

Retrieved 2026-10-02 · openFDA dataset updated 2026-10-02 · Check the current DailyMed label

Label records can cover multiple strengths or package sizes. A label listing does not by itself establish FDA approval or current market availability. Check the source and application history for this specific product.

Uses described in the label

INDICATIONS AND USAGE LidoSpra™ is indicated for topical analgesia and for the temporary relief of pain and itching associated with minor burns, sunburn, minor cuts, scrapes, insect bites, minor skin irritations, and rashes due to poison ivy, poison oak, or poison sumac, or as directed by a healthcare provider.
Dosage and administration — label text
DOSAGE AND ADMINISTRATION Spray the affected area in sufficient quantity 2 to 4 times daily as needed or as directed by a healthcare provider.
Contraindications
CONTRAINDICATIONS LidoSpra™ is contraindicated in patients with known hypersensitivity to lidocaine or any component of the formulation.
Warnings
WARNINGS For external use only. Avoid contact with eyes. If irritation, sensitivity, or infection occurs, discontinue use. Keep out of reach of children.
Product description
DESCRIPTION LidoSpra™ is a topical spray containing Lidocaine 4.12%.
Precautions
PRECAUTIONS Use only as directed. Excessive application may result in increased systemic absorption of lidocaine.
Supply and packaging
REFERENCES LidoSpra™ (Lidocaine 4.12%) is supplied as a topical spray in a 30 mL (1 fl oz) container. NDC 85477-325-29 Store at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature.]

Official sources and product identifiers

Substances listed: LIDOCAINE

RxNorm identifiers: 2749997

Package NDC codes

85477-325-29

Further research and background

These are external searches for related information. Research, encyclopedia and news articles have not been imported into this product record.

Coverage and corrections

The text is extracted from a US structured product label. Tables are represented as text where supplied; formatting and illustrations may be lost. A missing section does not mean a risk is absent. This reference has not been independently reviewed by a clinician and is not a live safety-alert service.

Source retrieved 2026-10-02. Read the source policy.